HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norio Hayashi Selected Research

asialo GM1 ganglioside

3/2007Natural killer cell-mediated ablation of metastatic liver tumors by hydrodynamic injection of IFNalpha gene to mice.
8/2003CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norio Hayashi Research Topics

Disease

54Neoplasms (Cancer)
01/2016 - 01/2002
47Chronic Hepatitis C
06/2020 - 01/2002
44Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2002
31Infections
06/2022 - 01/2002
13Fibrosis (Cirrhosis)
06/2020 - 07/2005
13Prostatic Neoplasms (Prostate Cancer)
07/2016 - 01/2002
13Chronic Hepatitis B
07/2015 - 07/2005
12Liver Cirrhosis (Hepatic Cirrhosis)
05/2019 - 10/2003
10Virus Diseases (Viral Diseases)
07/2015 - 02/2003
10Liver Diseases (Liver Disease)
03/2013 - 07/2004
9Neoplasm Metastasis (Metastasis)
11/2013 - 03/2002
9Chronic Hepatitis (Chronic Active Hepatitis)
05/2012 - 10/2003
8Hepatitis C
06/2022 - 07/2004
8Colonic Neoplasms (Colon Cancer)
09/2013 - 03/2002
7Carcinogenesis
11/2013 - 01/2005
6Liver Neoplasms (Liver Cancer)
09/2016 - 01/2007
6Inflammation (Inflammations)
11/2013 - 02/2002
6Obesity
04/2012 - 10/2007
5Anemia
03/2015 - 09/2006
5Carcinoma (Carcinomatosis)
10/2007 - 03/2002
4Renal Cell Carcinoma (Grawitz Tumor)
11/2013 - 07/2003
4Fatty Liver
04/2013 - 07/2009
4Hepatitis B
05/2012 - 01/2003
4Crohn Disease (Crohn's Disease)
05/2012 - 05/2008
4Colitis
05/2012 - 06/2008
4Colorectal Neoplasms (Colorectal Cancer)
11/2011 - 08/2007
4Ulcerative Colitis
04/2011 - 02/2002
4Hypoadiponectinemia
08/2010 - 06/2006
3Nausea
04/2016 - 09/2009
3Diarrhea
04/2016 - 05/2006
3Stomach Neoplasms (Stomach Cancer)
11/2013 - 10/2007
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2012 - 05/2008
3Cholestasis
03/2011 - 01/2008
3Stomach Ulcer (Gastric Ulcer)
03/2008 - 05/2006
3Ulcer
03/2008 - 05/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 11/2005

Drug/Important Bio-Agent (IBA)

38Ribavirin (Virazole)FDA LinkGeneric
10/2016 - 07/2004
33InterferonsIBA
05/2019 - 01/2002
12Antiviral Agents (Antivirals)IBA
06/2022 - 01/2006
12AdiponectinIBA
03/2013 - 10/2007
11Proteins (Proteins, Gene)FDA Link
07/2012 - 01/2003
11Lamivudine (Epivir)FDA Link
05/2012 - 07/2005
9RNA (Ribonucleic Acid)IBA
08/2014 - 02/2002
9micaIBA
09/2012 - 02/2003
8SimeprevirIBA
06/2020 - 01/2014
8entecavirFDA Link
07/2015 - 06/2008
8CytokinesIBA
08/2011 - 08/2006
7AntigensIBA
03/2013 - 03/2002
7Peptides (Polypeptides)IBA
11/2011 - 01/2007
6Sorafenib (BAY 43-9006)FDA Link
09/2016 - 04/2010
6VaccinesIBA
11/2011 - 01/2006
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2011 - 03/2007
6MHC class I-related chain AIBA
06/2010 - 02/2003
5DNA (Deoxyribonucleic Acid)IBA
07/2015 - 02/2006
5NucleosidesIBA
07/2015 - 01/2009
5Alanine Transaminase (SGPT)IBA
04/2013 - 01/2006
5LigandsIBA
07/2009 - 11/2003
4telaprevirIBA
07/2017 - 01/2012
4Epidermal Growth Factor (EGF)IBA
04/2013 - 10/2007
4Immunoglobulin G (IgG)IBA
05/2012 - 05/2008
4OligosaccharidesIBA
05/2012 - 05/2008
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2012 - 03/2002
4Interferon-alpha (Interferon Alfa)IBA
09/2010 - 07/2003
4alpha-galactosylceramideIBA
06/2009 - 08/2003
3Fetal Proteins (Fetoprotein)IBA
05/2019 - 07/2014
3AndrogensIBA
07/2016 - 06/2012
3peginterferon alfa-2b (Pegintron)FDA Link
04/2016 - 04/2011
3BilirubinIBA
03/2016 - 01/2006
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2015 - 12/2007
3Hemoglobins (Hemoglobin)IBA
03/2015 - 09/2006
3MicroRNAs (MicroRNA)IBA
11/2013 - 05/2010
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2013 - 01/2006
3CholesterolIBA
04/2013 - 08/2010
3Small Interfering RNA (siRNA)IBA
12/2012 - 10/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012 - 08/2007
3Interleukin-10 (Interleukin 10)IBA
05/2012 - 01/2006
3lipoarabinomannan (LAM)IBA
05/2012 - 05/2008
3NucleotidesIBA
05/2012 - 01/2007
3Celecoxib (Celebrex)FDA Link
04/2012 - 10/2003
3Pharmaceutical PreparationsIBA
03/2012 - 01/2009
3Glycoproteins (Glycoprotein)IBA
03/2011 - 10/2003
3Biological ProductsIBA
02/2011 - 10/2003
3adefovir dipivoxil (Hepsera)FDA Link
05/2009 - 01/2009
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2008 - 03/2002
3Transforming Growth Factor beta (TGF-beta)IBA
11/2008 - 10/2004
3Toll-Like Receptors (Toll-Like Receptor)IBA
06/2008 - 09/2007
3Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2008 - 04/2003
3Acetic Acid (Vinegar)FDA LinkGeneric
03/2008 - 05/2006
2Branched-Chain Amino AcidsIBA
09/2016 - 07/2013
2vaniprevirIBA
04/2016 - 02/2015

Therapy/Procedure

59Therapeutics
07/2017 - 02/2002
7Radiotherapy
07/2016 - 09/2005
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
07/2016 - 11/2012
4Drug Therapy (Chemotherapy)
10/2009 - 04/2005
4Prostatectomy (Retropubic Prostatectomy)
05/2006 - 01/2002
3Radiofrequency Ablation
07/2015 - 06/2008
3Immunotherapy
09/2013 - 10/2007
3Intraperitoneal Injections
07/2010 - 01/2006
3Transplantation
02/2009 - 01/2008
2Retreatment
07/2017 - 05/2007